Ticlid seems to increase the risk of another potentially fatal blood disorder

May 1998

Ticlid seems to increase the risk of another potentially fatalblood disorder...thrombotic thrombocytopenic purpura (TTP).

Ticlid patients are already being monitored for neutropenia...now there are at least 60 reports of TTP.

TTP leads to thrombocytopenia...anemia...renal dysfunction...and neurologic changes that can be confused with a stroke. About 30%of these patients die.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote